biomed devic servic
model updat reiter hold target
updat model includ estim increas price
target roll valuat estim reiter
hold rate
price close busi januari
intuit surgic manufactur da vinci robot system
use wide rang minimally-invass surgic
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
deriv price target appli ratio line large-
cap med-tech comp group ep model forward ep
compound-annual-growth-rate thu aforement target multipl drive target price-to-earnings
appli deriv target
hold unchang target price januari
biomed devic servic
p/e/g valuat financi metric use mean large-cap medic devic price-to-earnings multipl ep pro forma price-to-earnings multipl use group forma year-end cash jan asr factor valuat analysi figur incom statement
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
hold unchang target price januari
biomed devic servic
million except per share total servic total gross total oper oper incom expens pre-tax incom tax expens tax incom share ep pro-forma calcul xi trade-in base compens intang liabil litig invest net forma ex tax forma normal margin analysisduct adjust sbc ia margin pro margin includ margin pro incom cont figur revenu model
hold unchang target price januari
biomed devic servic
total instrument/access total servic total revenu growth modelgrowth rate assumptionsu system unit sale replacements/trad instal base us intern total total sold ex-oper asp modelgrowth rate procedur growth procedur growth procedur growth gener ou urolog gener gynecolog us ww procedur asp revenue/instal system intuit surgic
author analyst canaccord genuiti whose name appear front page research herebi certifi
recommend opinion express research accur reflect author analyst person independ
object view design invest relev issuer discuss herein within author
analyst coverag univers ii part author analyst compens directli indirectli relat
specif recommend view express author analyst research
analyst employ outsid us regist research analyst finra analyst may associ person
canaccord genuiti inc therefor may subject finra rule nyse rule restrict commun
subject compani public appear trade secur held research analyst account
individu identifi sector coverag cover subject compani industri identifi jurisdict author
analyst report
date time first dissemin januari et
date time product januari et
deriv price target appli ratio line large-cap med-tech comp group ep
model forward ep compound-annual-growth-rate thu aforement target multipl drive target price-to-earnings appli
deriv target
risk achiev target price valuat
capit spend environ spend wors think could neg impact revenu stock
procedur gather steam aggreg
competit tools/techniqu cheaper -- easier learn faster use -- product avail doc may find
much prefer use robot
increas competit robot space expect near term cheaper platform potenti take futur capit share
share volatil creat risk volatil add uncertainti invest share
distribut rate
global stock rate
total includ stock review
buy stock expect gener risk-adjust return next month
hold stock expect gener risk-adjust return next month
sell stock expect gener neg risk-adjust return next month
rate canaccord genuiti provid research coverag relev issuer
risk-adjust return refer expect return relat amount risk associ design invest
hold unchang target price januari
biomed devic servic
specul stock bear significantli higher risk typic valu normal fundament criteria invest
stock may result materi loss
recommend histori date global stock rate tabl
list recommend issuer coverag dissemin preced period
may obtain follow websit provid hyperlink report read electron http //disclosures-
requir company-specif disclosur date public
